Comera life sciences announces bridge financing and exercise of take private option

Woburn, mass., jan. 04, 2024 (globe newswire) -- comera life sciences holdings, inc. (otcqb: cmra) (“comera” or the “company”), a life sciences company developing a proprietary drug-delivery technology to improve patient access, safety, and convenience, today announced the closing of a bridge financing with a syndicate of investors. following the closing, the investors exercised a purchase option to acquire all of the outstanding common stock of the company not already held by the investors to take the company private. the financing and option exercise follows a robust effort by the company, led by a special committee of the company's board of directors, to explore strategic alternatives to maximize shareholder value.
CMRA Ratings Summary
CMRA Quant Ranking